Editorial: Tumor Microenvironment and Resistance to Current Therapies

Front Oncol. 2019 Nov 14:9:1131. doi: 10.3389/fonc.2019.01131. eCollection 2019.

Authors

Ahmed Lasfar^{1

2}, Murugabaskar Balan³, Karine A Cohen-Solal¹, Andrew Zloza⁴

Affiliations

¹ Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
² Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
³ Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
⁴ Rush University Medical Center, Chicago, IL, United States.

No abstract available

Keywords: cancer cell signaling; cancer resistance; immunotherapy; targeted therapy; therapy resistance; tumor microenvironment; tumor—targeting.

Publication types

Editorial

Grants and funding

R01 CA225993/CA/NCI NIH HHS/United States